Cargando…

New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy

SIMPLE SUMMARY: Although colorectal cancer is the third most common type of cancer, its treatment strategies still have room for improvement, as current techniques carry risks that aggressively deteriorate patients’ quality of life. Medical physics using nanotechnology tools can significantly contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Freitas, Sara C., Sanderson, Daniel, Caspani, Sofia, Magalhães, Ricardo, Cortés-Llanos, Belén, Granja, Andreia, Reis, Salette, Belo, João Horta, Azevedo, José, Gómez-Gaviro, Maria Victoria, de Sousa, Célia Tavares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856291/
https://www.ncbi.nlm.nih.gov/pubmed/36672333
http://dx.doi.org/10.3390/cancers15020383
_version_ 1784873584662937600
author Freitas, Sara C.
Sanderson, Daniel
Caspani, Sofia
Magalhães, Ricardo
Cortés-Llanos, Belén
Granja, Andreia
Reis, Salette
Belo, João Horta
Azevedo, José
Gómez-Gaviro, Maria Victoria
de Sousa, Célia Tavares
author_facet Freitas, Sara C.
Sanderson, Daniel
Caspani, Sofia
Magalhães, Ricardo
Cortés-Llanos, Belén
Granja, Andreia
Reis, Salette
Belo, João Horta
Azevedo, José
Gómez-Gaviro, Maria Victoria
de Sousa, Célia Tavares
author_sort Freitas, Sara C.
collection PubMed
description SIMPLE SUMMARY: Although colorectal cancer is the third most common type of cancer, its treatment strategies still have room for improvement, as current techniques carry risks that aggressively deteriorate patients’ quality of life. Medical physics using nanotechnology tools can significantly contribute to solving this challenge. The high biocompatibility, easy functionalization, and targeting capabilities of plasmonic (gold) nanoparticles, together with their high atomic number, which provides a large X-ray absorption cross-section, makes them potential agents for enhancing cancer therapeutics as photothermal therapy agents and as radiosensitizers. Hence, the auspicious possibility of synergistically combining radio- and phototherapies is of imperative importance and must be explored to enhance their clinical application. ABSTRACT: Colorectal cancer is the third most common cancer worldwide. Despite recent advances in the treatment of this pathology, which include a personalized approach using radio- and chemotherapies in combination with advanced surgical techniques, it is imperative to enhance the performance of these treatments and decrease their detrimental side effects on patients’ health. Nanomedicine is likely the pathway towards solving this challenge by enhancing both the therapeutic and diagnostic capabilities. In particular, plasmonic nanoparticles show remarkable potential due to their dual therapeutic functionalities as photothermal therapy agents and as radiosensitizers in radiotherapy. Their dual functionality, high biocompatibility, easy functionalization, and targeting capabilities make them potential agents for inducing efficient cancer cell death with minimal side effects. This review aims to identify the main challenges in the diagnosis and treatment of colorectal cancer. The heterogeneous nature of this cancer is also discussed from a single-cell point of view. The most relevant works in photo- and radiotherapy using nanotechnology-based therapies for colorectal cancer are addressed, ranging from in vitro studies (2D and 3D cell cultures) to in vivo studies and clinical trials. Although the results using nanoparticles as a photo- and radiosensitizers in photo- and radiotherapy are promising, preliminary studies showed that the possibility of combining both therapies must be explored to improve the treatment efficiency.
format Online
Article
Text
id pubmed-9856291
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98562912023-01-21 New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy Freitas, Sara C. Sanderson, Daniel Caspani, Sofia Magalhães, Ricardo Cortés-Llanos, Belén Granja, Andreia Reis, Salette Belo, João Horta Azevedo, José Gómez-Gaviro, Maria Victoria de Sousa, Célia Tavares Cancers (Basel) Review SIMPLE SUMMARY: Although colorectal cancer is the third most common type of cancer, its treatment strategies still have room for improvement, as current techniques carry risks that aggressively deteriorate patients’ quality of life. Medical physics using nanotechnology tools can significantly contribute to solving this challenge. The high biocompatibility, easy functionalization, and targeting capabilities of plasmonic (gold) nanoparticles, together with their high atomic number, which provides a large X-ray absorption cross-section, makes them potential agents for enhancing cancer therapeutics as photothermal therapy agents and as radiosensitizers. Hence, the auspicious possibility of synergistically combining radio- and phototherapies is of imperative importance and must be explored to enhance their clinical application. ABSTRACT: Colorectal cancer is the third most common cancer worldwide. Despite recent advances in the treatment of this pathology, which include a personalized approach using radio- and chemotherapies in combination with advanced surgical techniques, it is imperative to enhance the performance of these treatments and decrease their detrimental side effects on patients’ health. Nanomedicine is likely the pathway towards solving this challenge by enhancing both the therapeutic and diagnostic capabilities. In particular, plasmonic nanoparticles show remarkable potential due to their dual therapeutic functionalities as photothermal therapy agents and as radiosensitizers in radiotherapy. Their dual functionality, high biocompatibility, easy functionalization, and targeting capabilities make them potential agents for inducing efficient cancer cell death with minimal side effects. This review aims to identify the main challenges in the diagnosis and treatment of colorectal cancer. The heterogeneous nature of this cancer is also discussed from a single-cell point of view. The most relevant works in photo- and radiotherapy using nanotechnology-based therapies for colorectal cancer are addressed, ranging from in vitro studies (2D and 3D cell cultures) to in vivo studies and clinical trials. Although the results using nanoparticles as a photo- and radiosensitizers in photo- and radiotherapy are promising, preliminary studies showed that the possibility of combining both therapies must be explored to improve the treatment efficiency. MDPI 2023-01-06 /pmc/articles/PMC9856291/ /pubmed/36672333 http://dx.doi.org/10.3390/cancers15020383 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Freitas, Sara C.
Sanderson, Daniel
Caspani, Sofia
Magalhães, Ricardo
Cortés-Llanos, Belén
Granja, Andreia
Reis, Salette
Belo, João Horta
Azevedo, José
Gómez-Gaviro, Maria Victoria
de Sousa, Célia Tavares
New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
title New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
title_full New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
title_fullStr New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
title_full_unstemmed New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
title_short New Frontiers in Colorectal Cancer Treatment Combining Nanotechnology with Photo- and Radiotherapy
title_sort new frontiers in colorectal cancer treatment combining nanotechnology with photo- and radiotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856291/
https://www.ncbi.nlm.nih.gov/pubmed/36672333
http://dx.doi.org/10.3390/cancers15020383
work_keys_str_mv AT freitassarac newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT sandersondaniel newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT caspanisofia newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT magalhaesricardo newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT cortesllanosbelen newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT granjaandreia newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT reissalette newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT belojoaohorta newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT azevedojose newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT gomezgaviromariavictoria newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy
AT desousaceliatavares newfrontiersincolorectalcancertreatmentcombiningnanotechnologywithphotoandradiotherapy